In Brief: Wyeth/Elan Naprelan

Executive Summary

Wyeth/Elan Naprelan: Elan Pharma neurological sales force of 60 reps will begin promoting Naprelan (naproxen controlled-release) to neurologists, and physical medicine and rehabilitation specialists. Wyeth-Ayerst has been marketing the once-daily arthritis pain medication, which uses Elan's Intestinal Protective Drug Absorption System, to general practitioners, family practice and internal medicine physicians since April 1996. Naprelan is the first product to be marketed by the Elan Pharma neurological sales force. The group plans to promote Elan subsidiary Athena's anti-epileptic Diastat (diazepam gel), which the firm expects to be approved later this year...